Cheyenne Wyoming, June 30, 2016 (GLOBE NEWSWIRE) -- MedX Holdings, Inc. (OTC PINK: MEDH) today announces that our subsidiary MedX Pharmaceuticals, has made nothing more than amazing progress! MedX Pharmaceuticals has within a very short period of time secured a 5-Year renewable lease on a warehouse facility at 750 Lakeside Drive, Mobile Alabama 36693. At this location, ADT Security has wired and secured the property with motion sensors and cameras that now meet FDA guidelines. Comcast has provided phone, TV and Internet as well as a static IP which also meets FDA guidelines. In addition, we have secured a very reputable local contractor who is fully committed and is presently on task remodeling of our office space.
Now for the biggest game-changing news! MedX Pharmaceuticals, Inc. is now a fully licensed wholesale distributor of pharmaceuticals in the state of Alabama. This now positions MedX to immediately begin selling our 5% Lidocaine Ointment in the 50 gm jars!
Ms. Roberton, CEO commented: “MedX has made remarkable progress is such a short period of time. We now have several states that we can legally sell in which positions MEDH to finally begin the Revenue Phase”. “Our Office/Warehouse allows us to easily expand into a “Clean Room” to begin manufacturing 3 other OTC Market products while we are selling the RX 5% Lidocaine Ointment
MedX Holdings, Inc. is a publicly trading holding company utilizing a new form of Collaborative Governance. MEDH targets the acquisitions of undervalued, turnaround medical related businesses. In addition, MedX Pharmaceuticals a wholly-owned subsidiary of MEDH is newly emerging as a dynamic distributor of pharmaceutical products.
For more information about MedX Holdings, Inc., call (877) 225-0243 or visit our web site www.medxholdings.com is located at 1621 Central Avenue, Cheyenne, WY, USA
Safe-Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company’s financing plans; (ii) trends affecting the company’s financial condition or results of operations; (iii) the company’s growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the company’s Forms 10-K and 10-Q filed with the SEC.
Phone: 877-225-0243 Email: email@example.com
Source:MedX Holdings, Inc.